Companies Related to "Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer" [Most Relevant Company Matches] RSS

23:29 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Doxorubicin Hydrochloride Liposome First Line Therapy Treating Older" Companies 1–25 of 2,800+

Extremely Relevant


NeoPharm is a pharmaceutical Company engaged in the research and development of drugs for the diagnosis and treatment of various forms of cancer. Presently the Company has several drugs which are in varying stages of development: BUdR(Broxuridine), liposome encapsulated doxorubicin ("LED"), liposome encapsulated paclitaxel ("LEP"), liposome encapsulated antisense oligodeoxynucleotide ("LE-AON" and...


Aegis Therapies

Aegis Therapies is one of the largest and most successful contract rehabilitation companies in the country, with operations at more than 1,000 locations in 37 states and the District of Columbia, and more than 7,000 employees. Aegis specializes in therapy that is needed by nursing home, assisted living or home-bound patients with medically complex conditio...

Purdue Office of Technology Commercialization

People 65 and older are America's fastest-growing population, a category particularly at risk for falls. In 2010 about 21,700 older adults died from unintentional fall injuries, and 2.3 million nonfatal fall injuries among older adults were treated in emergency departments.

Liposome Company Incorporated

The Liposome Company Incorporated. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. The Company's marketed product and products in development are based on its knowledge and understanding of lipi...

Radius Health, Inc.

Radius is a biopharmaceutical company focused on developing and commercializing advanced therapeutics to support healthy aging. We aspire to improve the quality of life in older adults by treating age-related conditions.


ViroLogic, a privately held South San Francisco-based biotechnology company, is a leader in the development of novel therapy guidance tools to enable patients, physicians, and medical reimbursers to make rational treatment decisions in the management of viral diseases. The company's proprietary technology is also being used in the fields of viral pharmacogenomics to identify, analyze, and select n...

HelpAge USA

HelpAge USA, an affiliate of HelpAge International, builds awareness of global aging issues among US audiences; advocates for the empowerment of older, vulnerable adults in the developing world; and raises funds to support the programs of the HelpAge network. HelpAge International helps older people around the world lead full and secure lives. It is the only global network focused on the needs and...

Taiwan Liposome Company

GelTex Incorporated

We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s first product, Renagel® brand sevelamer hydrochloride, was granted marketing approval by the U.S. Food and Drug Administration (FDA) in October 1998 for the reduction of serum phosphorus in hemodialy...

Center for Medicines & Health Aging

The Center for Medicines & Healthy Aging(C) (CMHA) is the premier authoritative consumer-oriented website designed to educate older adults and caregivers about principles and practices associated with safe and appropriate use of medicines in older adults. Although a number of websites provide general drug information, CMHA is intended to provide practical, unbiased information focused on medicine ...

VirRx, Inc.

VirRx, Inc., is a biotechnology company with a primary interest in cancer gene therapy. Its broad mission is to develop genetically modified "smart bomb" adenoviruses for use in treating human cancers. Adenoviruses are ubiquitous, benign viruses that are one of the causes of the common cold.VirRx scientists are experts on human adenoviruses, including construction of human adenovirus vectors for c...

John A. Hartford Foundation

Founded in 1929, the John A. Hartford Foundation’s mission is to improve the health of older Americans. The Foundation is a committed champion of health care training, research, and service system innovations that will ensure the well-being and vitality of older adults. For more information, please visit

Transave, Inc.

Transave, Inc., is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of chronic lung diseases. The company's major focus is on developing antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. The Transave team is dedicated to leveraging its develo...

Therapy Source, Inc.

Therapy Source, a premier therapy staffing provider, offers highly qualified speech, occupational, physical, psychological and related therapy services to educational and healthcare organizations. For more information on Therapy Source, visit or call toll free at 866-783-5301.

Bio-Path Holdings, Inc.

Bio-Path is developing a patented, liposomal drug delivery system and products developed at The University of Texas M. D. Anderson Cancer Center, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development.

Phares AG

Phares AG, located in Basel, Switzerland provides a range of services and products to develop dosage forms for insoluble compounds. Phares 360 services ( include pharmaceutical profiling for lead selection (Survey), rapid solutions for tox testing (Speed) and developing clinical formulations with enhanced bioavailability (Icebreaker). These services use a variety of specific tech...


PERCIVIA LLC develops recombinant therapeutic proteins using the PER.C6® human cell line, with a focus on bio-better and bio-similar projects. PERCIVIA has developed a highly efficient protein production platform based on the PER.C6®cell line for the production of human therapeutic proteins with native human characteristics, at extremely high yields....

FeRx Incorporated

The Company is focused on the development and commercialization of its proprietary Magnetic Targeted Carrier ("MTC") technology for the site specific delivery and sustained release of pharmaceutical agents. FeRx's lead compound, MTC-Doxorubicin, is in Phase I/II clinical trials in patients with liver cancer.

CarrollDrugs.Com - The online department of Taneytown Pharmacy

Carroll Drugs offers full line pharmacy services and features hormone replacement therapy with local and national delivery. In addition to traditional prescriptions, we compound medications specific to each patient by order of a physician, such as hormone replacement therapy. E-mail or call us us to find out about our VERY reasonable prices on drugs and compounds like bio-identical hormone replac...

VisCardia Inc

VisCardia based in Portland, OR is developing a novel implantable device therapy for treating heart failure, a condition that afflicts 10 million patients in the U.S. and Europe. To learn more about VisCardia, visit:

VisCardia Inc.

VisCardia, based in Portland, OR, is developing a novel implantable device therapy for treating heart failure, a condition that afflicts 10 million patients in the U.S. and Europe. To learn more about VisCardia, visit:


Founded in 1982, with a vision of using heat to kill cancer and treat other diseases, Celsion began trading publicly in 1985 under the name Cheung Laboratories, Inc. The early research focus of the Company was device oriented heat-based treatment systems. The Company was renamed Celsion Corporation and listed on the American Stock Exchange under the symbol CLN, in the mid 1990's. At that time, Cel...

CDH Proton Center

CDH Proton Center, A ProCure Center, Warrenville, Ill., is one of a handful of facilities in the country that offer proton therapy, an advanced form of radiation to treat cancer. The four-room, 60,000 sq. ft. Center, opened Oct. 19, 2010, is the first for Illinois and has the capacity to treat up to 1,500 patients a year. The precision of proton therapy sp...

Allergy Immuno Technologies Incorporated

Allergy Immuno Technologies, Inc. (AIT) and its predecessors commenced development activities in allergy and immune disorder research diagnostic reagents and services in 1980. AIT currently operates a clinical reference laboratory at 1527 Monrovia Avenue, Newport Beach, CA, for allergy and other diagnostic testing services for physicians, other laboratories and pharmaceutical companies. As a resul...

Hygieia, Inc.

Hygieia, Inc. is an emerging diabetes health care company developing new ways to improve the effectiveness of therapy while reducing the cost of diabetes care. Hygieia’s first product is a handheld Diabetes Insulin Guidance System (DIGS™) designed to improve insulin therapy effectiveness for patients. DIGS works in a way that makes it a feasible ...

More From BioPortfolio on "Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer"

Quick Search


Corporate Database Quicklinks